Search Results

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).

• Authors : Comi G; Patti F ...

Subjects: Cognition Disorders*/Cognition Disorders*/Cognition Disorders*/diagnostic imaging ; Cognition Disorders*/Cognition Disorders*/Cognition Disorders*/drug therapy ; Cognition Disorders*/Cognition Disorders*/Cognition Disorders*/etiology

• Source: Journal of neurology [J Neurol] 2017 Dec; Vol. 264 (12), pp. 2436-2449. Date of Electronic Publication: 2017 Oct 23.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.

• Authors : Brown RA; From the McConnell Brain Imaging Centre (R.A.B., S.N., N.S., D.L.A.), Montreal Neurological Institute and Hospital, Canada; Rutgers-New Jersey Medical School (S.C., D.C.), Newark, NJ

Subjects: Brain Injuries*/Brain Injuries*/Brain Injuries*/diagnostic imaging ; Brain Injuries*/Brain Injuries*/Brain Injuries*/etiology ; Brain Injuries*/Brain Injuries*/Brain Injuries*/pathology

• Source: Neurology [Neurology] 2016 Aug 30; Vol. 87 (9), pp. 905-11. Date of Electronic Publication: 2016 Jul 29.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium:

Record details

A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.

• Authors : Najafi, Soheil (AUTHOR); Moghadam, Nahid Beladi (AUTHOR); Saadat, Payam (AUTHOR)

Subjects: MULTIPLE sclerosis; INTERFERON beta 1b; CLINICAL trials

• Source: International Journal of Neuroscience. Apr2022, Vol. 132 Issue 4, p403-412. 10p.

Record details

Mitoxantrone and interferon beta-1b regimen shows promise.

• Source: World Disease Weekly. 2005, pages. 1196

Record details

Mitoxantrone and interferon beta-1b regimen shows promise.

• Source: Health & Medicine Week. 2005, pages. 1196

Record details

Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.

• Authors : Goodin, Douglas S; Reder, Anthony T; Traboulsee, Anthony L

Subjects: PREDICTIVE validity; INTERFERONS; MAGNETIC resonance imaging

• Source: Multiple Sclerosis Journal; May2019, Vol. 25 Issue 6, p837-847, 11p, 4 Charts

Record details

New Multiple Sclerosis Findings Has Been Reported by Investigators at Department of Neurology [Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, ...]

• Source: Health & Medicine Week. December 15, 2017, 3223

Record details

A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis.

• Authors : Pietrzak, Anna; Kalinowska-Łyszczarz, Alicja; Osztynowicz, Krystyna

Subjects: SUPPRESSORS of cytokine signaling; MULTIPLE sclerosis; INTERFERONS

• Source: Advances in Clinical & Experimental Medicine; Jul2020, Vol. 29 Issue 7, p841-851, 11p

Record details

Mitoxantrone and interferon beta-1b regimen shows promise

• Source: Health & Medicine Week. July 18, 2005, p1196

Record details

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.

• Authors : Montalban, X.; Sastre-Garriga, J.; Tintoré, M.

Subjects: MULTIPLE sclerosis treatment; THERAPEUTIC use of interferons; DRUG efficacy

• Source: Multiple Sclerosis (13524585); Oct2009, Vol. 15 Issue 10, p1195-1205, 11p, 1 Diagram, 3 Charts, 1 Graph

Record details